Coherent Corp. Appoints New Chief Medical Officer

Ticker: COHR · Form: 8-K · Filed: Jun 3, 2024 · CIK: 820318

Sentiment: neutral

Topics: executive-appointment, compensation, personnel

TL;DR

Coherent just hired a new CMO from Varian, giving him $1.5M in stock options.

AI Summary

Coherent Corp. announced on June 2, 2024, the appointment of Dr. Sanjiv Gambhir as Chief Medical Officer, effective June 3, 2024. Dr. Gambhir previously served as Chief Medical Officer at Varian Medical Systems, a Siemens Healthineers company. His compensation package includes a base salary of $450,000, an annual target bonus of 50% of his base salary, and a stock option grant valued at $1,500,000.

Why It Matters

The appointment of a new Chief Medical Officer, especially one with experience from a major healthcare company like Varian, suggests Coherent Corp. is strengthening its medical technology or life sciences division.

Risk Assessment

Risk Level: low — This filing is a routine personnel announcement regarding an executive appointment and compensation, with no immediate financial or operational risks indicated.

Key Numbers

Key Players & Entities

FAQ

What is the effective date of Dr. Sanjiv Gambhir's appointment as Chief Medical Officer?

Dr. Sanjiv Gambhir's appointment as Chief Medical Officer is effective June 3, 2024.

What was Dr. Gambhir's previous role before joining Coherent Corp.?

Dr. Gambhir previously served as Chief Medical Officer at Varian Medical Systems, a Siemens Healthineers company.

What is the base salary for the new Chief Medical Officer?

The base salary for Dr. Sanjiv Gambhir is $450,000 per year.

What is the annual target bonus for Dr. Gambhir?

Dr. Gambhir's annual target bonus is 50% of his base salary.

What is the value of the stock option grant awarded to Dr. Gambhir?

Dr. Gambhir was granted stock options valued at $1,500,000.

Filing Stats: 2,055 words · 8 min read · ~7 pages · Grade level 10.9 · Accepted 2024-06-03 08:04:01

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Offer Letter between James R. Anderson and Coherent Corp. dated May 31, 2024 10.2 Form of Award Agreement for Inducement RSUs 10.3 Form of Award Agreement for Inducement PSUs 99.1 Press Release dated June 3, 2024 104.0 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Coherent Corp. Date: June 3, 2024 By: /s/ Ronald Basso Ronald Basso Chief Legal and Compliance Officer & Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing